The U.S. Food and Drug Administration has approved Incyte's eczema treatment for children aged between 2 and 11 years, the ...

World Atopic Eczema Day 2025 calls for early intervention, better care and greater awareness of the hidden toll of atopic ...

Data from the late-stage trial of amlitelimab weren’t as strong as the results seen in Phase 2, adding to doubts about a drug ...

Please provide your email address to receive an email when new articles are posted on . In this video, Jeff Yu, MD, MS, emphasized the importance of chronic hand eczema awareness and highlighted a ...

LEO Pharma Inc. announced today that the Food and Drug Administration (FDA) has approved ANZUPGO® (delgocitinib) cream for the topical treatment of moderate-to-severe chronic hand eczema (CHE) in ...

World Atopic Eczema Day 2025 highlights the lifelong impact of atopic eczema, a common inflammatory skin disease that often begins in infancy and can lead to food allergies, asthma, and other allergic ...

Face masks are having a moment — but not the creamy kind you slather all over your skin and wash off after 10 minutes of sitting as still as a statue while watching Netflix. The type we're referring ...

Sanofi shares plunged after its experimental drug for the skin condition atopic dermatitis disappointed investors with a less-than-expected benefit in a late-stage trial.After 24 weeks of treatment, ...

A new international study presented at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that ...